Cas13d: Small RNA-targeting CRISPR enzymes for transcriptome engineering
Type
Blog Post
Published
May 3, 2018, 1:48 p.m.
... dementia-associated tau, delivering dCasRx and a 3-spacer array targeting the MAPT exon 10 splice acceptor...for pre-clinical and clinical applications of dCasRx.
The identification of Type VI Cas13d enzymes is ...RspCas13d. RspWYL1 also increased EsCas13d activity, indicating that WYL domain-containing proteins may be broader...even when guides were tiled across a target RNA, indicating that this enzyme does not cleave at a predictable...target essentially any RNA in a cell.
Since catalytically dead dCasRx maintains its RNA-binding properties...